Publications
Take a look

Publications

21.11.2018

Feasibility of PET/CT system performance harmonisation for quantitative multicentre 89Zr studies

15.10.2018

Drug-Induced Interstitial Lung Disease: A Systematic Review

13.10.2018

Evaluation of the in vitro and in vivo characteristics of the novel89Zr-octacoordinated chelator DFO-cyclo* compared to the hexacoordinated DFO (Conference Abstract)

13.10.2018

Development and evaluation of a new Interleukin-2 PET radioligand Al[18F]RESCA-IL2: comparison with [18F]FB-IL2 (Conference Abstract)

26.09.2018

In vitro and in vivo evaluation of novel 89Zr-chelators (Conference Abstract)

24.09.2018

Accuracy, repeatability, and reproducibility of R1 in 12 small-animal MRI systems (Conference Abstract)

24.09.2018

Slow infusion improves precision of liver function measurements by DCE-MRI (Conference Abstract)

15.09.2018

Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced Interstitial Lung Disease (DIILD) (Conference Abstract)

15.09.2018

Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD) (Conference Abstract)

15.07.2018

Overview of the TRanslational Imaging in Drug SafeTy AssessmeNt (TRISTAN) IMI Consortium and Progress towards Standardization of MR Biomarkers of Liver Injury and Drug-Drug Interactions (Conference Abstract)

16.06.2018

Gadoxetate relaxivities increase significantly after hepatic uptake at clinical field strength impacting kinetic modelling for liver function analysis (Conference Abstract)

05.04.2018

In vitro and in vivo comparison of the novel 89Zr chelator DFO-cyclo* with DFO (Conference Abstract)

21.03.2018

Noninvasive Preclinical and Clinical Imaging of Liver Transporter Function Relevant to Drug-Induced Liver Injury

08.03.2018

In vivo models of Drug Induced ILD; tools to study and improve drug safety (Conference Abstract)

24.08.2017

89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.

12.04.2017

New TRISTAN Project Leverages Potential of Imaging Techniques in Drug Safety Assessment

Brussels, April 12 2017 – The Innovative Medicines Initiative (IMI) has approved the 5-year project TRISTAN focusing on validation of translational imaging methods as potential imaging biomarkers.